Ticker
PYXSCompany Name
PYXIS ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash Return on Invested Capital | Free Cash Flow | Invested Capital |
---|---|---|---|
6/30/2025 | -68.86% | $ -73.75M | $ 107.11M |
3/31/2025 | -48.39% | $ -59.5M | $ 122.94M |
12/31/2024 | -41.08% | $ -57.91M | $ 140.95M |
9/30/2024 | -30.92% | $ -53.87M | $ 174.22M |
6/30/2024 | -29.82% | $ -56.85M | $ 190.67M |
3/31/2024 | -32.76% | $ -67.14M | $ 204.94M |
12/31/2023 | -52.66% | $ -77.44M | $ 147.03M |
9/30/2023 | -51.03% | $ -81.43M | $ 159.56M |
6/30/2023 | -53.21% | $ -88.61M | $ 166.53M |
3/31/2023 | -57.51% | $ -99.16M | $ 172.41M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Inv. Capital
(=) CROIC
CROIC for PYXIS ONCOLOGY INC is calculated as follows: FCF [ $ -11.57M ] / Inv. Capital [ $ -14.87M ]
(=) CROIC [ 0% ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.46K |
---|---|
min | -43.78% |
max | 49.57% |
average | 2.84% |
median | 5.02% |
std | 15.02% |